These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26918655)

  • 1. Ultrafiltration of highly concentrated antibody solutions: Experiments and modeling for the effects of module and buffer conditions.
    Binabaji E; Ma J; Rao S; Zydney AL
    Biotechnol Prog; 2016 May; 32(3):692-701. PubMed ID: 26918655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrafiltration behavior of monoclonal antibodies and Fc-fusion proteins: Effects of physical properties.
    Baek Y; Singh N; Arunkumar A; Borys M; Li ZJ; Zydney AL
    Biotechnol Bioeng; 2017 Sep; 114(9):2057-2065. PubMed ID: 28464237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermolecular Interactions and the Viscosity of Highly Concentrated Monoclonal Antibody Solutions.
    Binabaji E; Ma J; Zydney AL
    Pharm Res; 2015 Sep; 32(9):3102-9. PubMed ID: 25832501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Small-Scale Process for Predicting Donnan and Volume Exclusion Effects During Ultrafiltration/Diafiltration Process Development.
    Abel J; Kosky A; Ball N; Bacon H; Kaushik R; Kleemann GR
    J Pharm Sci; 2018 May; 107(5):1296-1303. PubMed ID: 29339134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hollow fiber countercurrent dialysis for continuous buffer exchange of high-value biotherapeutics.
    Yehl CJ; Jabra MG; Zydney AL
    Biotechnol Prog; 2019 Mar; 35(2):e2763. PubMed ID: 30520568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrafiltration behavior of partially retained proteins and completely retained proteins using equally-staged single pass tangential flow filtration membranes.
    Arunkumar A; Zhang J; Singh N; Ghose S; Li ZJ
    Biotechnol Prog; 2018 Sep; 34(5):1137-1148. PubMed ID: 30019541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Histidine and Sucrose on the Biophysical Properties of a Monoclonal Antibody.
    Baek Y; Singh N; Arunkumar A; Zydney AL
    Pharm Res; 2017 Mar; 34(3):629-639. PubMed ID: 28035628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermolecular interactions in highly concentrated formulations of recombinant therapeutic proteins.
    Baek Y; Zydney AL
    Curr Opin Biotechnol; 2018 Oct; 53():59-64. PubMed ID: 29278833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mechanistic model to account for the Donnan and volume exclusion effects in ultrafiltration/diafiltration process of protein formulations.
    Yu Z; Moomaw JF; Thyagarajapuram NR; Geng SB; Bent CJ; Tang Y
    Biotechnol Prog; 2021 Mar; 37(2):e3106. PubMed ID: 33289341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH variations during diafiltration due to buffer nonidealities.
    Baek Y; Yang D; Singh N; Arunkumar A; Ghose S; Li ZJ; Zydney AL
    Biotechnol Prog; 2017 Nov; 33(6):1555-1560. PubMed ID: 28840650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High concentration biotherapeutic formulation and ultrafiltration: Part 1 pressure limits.
    Lutz H; Arias J; Zou Y
    Biotechnol Prog; 2017 Jan; 33(1):113-124. PubMed ID: 27452237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-criteria manufacturability indices for ranking high-concentration monoclonal antibody formulations.
    Yang Y; Velayudhan A; Thornhill NF; Farid SS
    Biotechnol Bioeng; 2017 Sep; 114(9):2043-2056. PubMed ID: 28464235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of ultra- and microfiltration in the presence and absence of secondary flow with polysaccharides, proteins, and yeast suspensions.
    Gehlert G; Luque S; Belfort G
    Biotechnol Prog; 1998; 14(6):931-42. PubMed ID: 9841658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of protein and solution properties on the Donnan effect during the ultrafiltration of proteins.
    Bolton GR; Boesch AW; Basha J; Lacasse DP; Kelley BD; Acharya H
    Biotechnol Prog; 2011; 27(1):140-52. PubMed ID: 21312362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pressure and flux profiles in bead-filled ultrafiltration/microfiltration hollow fiber membrane modules.
    Dai XP; Luo RG; Sirkar KK
    Biotechnol Prog; 2000; 16(6):1044-54. PubMed ID: 11101333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting diafiltration solution compositions for final ultrafiltration/diafiltration steps of monoclonal antibodies.
    Teeters M; Bezila D; Benner T; Alfonso P; Alred P
    Biotechnol Bioeng; 2011 Jun; 108(6):1338-46. PubMed ID: 21328314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buffer-free therapeutic antibody preparations provide a viable alternative to conventionally buffered solutions: from protein buffer capacity prediction to bioprocess applications.
    Bahrenburg S; Karow AR; Garidel P
    Biotechnol J; 2015 Apr; 10(4):610-22. PubMed ID: 25641961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of zinc chloride and PEG concentrations on the critical flux during tangential flow microfiltration of BSA precipitates.
    Li Z; Zydney AL
    Biotechnol Prog; 2017 Nov; 33(6):1561-1567. PubMed ID: 28840656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The osmotic pressure of highly concentrated monoclonal antibody solutions: effect of solution conditions.
    Binabaji E; Rao S; Zydney AL
    Biotechnol Bioeng; 2014 Mar; 111(3):529-36. PubMed ID: 23996891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sterile Filtration of Highly Concentrated Protein Formulations: Impact of Protein Concentration, Formulation Composition, and Filter Material.
    Allmendinger A; Mueller R; Huwyler J; Mahler HC; Fischer S
    J Pharm Sci; 2015 Oct; 104(10):3319-29. PubMed ID: 26149748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.